Oxidative stress is a critical mediator of the angiotensin II signal in human neutrophils: Involvement of mitogen-activated protein kinase, calcineurin, and the transcription factor NF-κB

Blood

Volumn 102, Issue 2, 2003, Pages 662-671

  El Bekay, Rajaa ^b   Álvarez, Moisés ^b   Monteseirín, Javier ^b   Álba, Gonzalo ^b   Chacón, Podre ^b   Vega, Antonio ^b   Martín Nieto, José ^b   Jiménez, Juan ^b   Pintado, Elízabeth ^b   Bedoya, Francisco J ^b   Sobrino, Francisco ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CALCINEURIN; CALCIUM ION; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; OXIDOREDUCTASE; OXIDOREDUCTASE INHIBITOR; PROTEIN; PROTEIN P47; PROTEIN P67; PROTEIN TYROSINE KINASE INHIBITOR; QUERCETIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STRESS ACTIVATED PROTEIN KINASE; SUPEROXIDE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM CELL LEVEL; CELL ACTIVATION; CELL CULTURE; CELL MEMBRANE TRANSPORT; CELL STIMULATION; CONTROLLED STUDY; CYTOSOL; DNA BINDING; ENZYME ACTIVITY; EXTRACELLULAR SPACE; HUMAN; HUMAN CELL; INHIBITION KINETICS; NEUTROPHIL; OXIDATIVE STRESS; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

EID: 20244378630     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-09-2785     Document Type: Article

References (77)

1. Ross R. Atherosclerosis, an inflammatory disease. N Engl J Med. 1999;340:115-126.
2. Peach MJ. Renin-angiotensin system: biochemistry and mechanism of action. Physiol Rev. 1977;57:313-370.
3. Timmermans PB, Wong PC, Chiu AT, et al. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev. 1993;45:205-251.
4. Ito H, Takemory K, Suzuki T. Role of angiotensin II type 1 receptor in the leukocytes and endothelial cells of brain microvessels in the pathogenesis of hypertensive cerebral injury. J Hypertens. 2001;19:591-597.
5. Shimada K, Yakazi Y. Binding sites for angiotensin II in human mononuclear leucocytes. J Biochem. 1978;84:1013-1015.
6. Hahn AW, Johas U, Buhler FR, Resink TJ. Activation of human peripheral monocytes by angiotensin II. FEBS Lett, 1994;347:178-180.
7. Mazzone A, De Servi S, Ricevuti G, et al. Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease. Circulation. 1993;88:358-363.
8. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 1994;74:1141-1148.
9. Finkel T. Oxyen radicals and signaling. Curr Opin Cell Biol. 1998;10:248-253.
10. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular disease: the role of oxidant stress. Circ Res. 2000;87:840-844.
11. Clarck RA, Volpp BD, Leidal KG, Nauseef VM. Two cytosolic components of the human neutrophils respiratory burst oxidase translocate to the plasma membrane during cell activation. J Clin Invest. 1990;85:714-721.
12. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H-oxidase: role in cardiovascular biology and disease. Circ Res. 2000;86:494-501.
13. Baeuerle PA, Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol. 1994;12:141-179.
14. 2. J Biol Chem. 1996;271:4138-4142.
15. Ushio-Fukai M, Alexander RW, Akers M, Griendling KK. p38 mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. J Biol Chem. 1998;273:15022-15029.
16. Pontremoli S, Salamino F, Sparatore B, et al. Enhanced activation of the respiratory burst oxidase in neutrophils from hypertensive patients. Biochem Biophys Res Commun. 1989;158:966-972.
17. Seifert R, Hilgenstock G, Fassbender M, Distler A. Regulation of the superoxide-forming NADPH oxidase of human neutrophils is not altered in essential hypertension. J Hypertens. 1991;9:147-153.
18. Skrede KK, Roshol H, Aero CE, Wiik P. Peritoneal leucocytes from spontaneously hypertensive rats have reduced chemiluminescence response and lowered sensitivity to dexamethasone in vivo. Acta Physiol Scand. 1996;158:169-179.
19. Alvarez A, Sanz MJ. Reactive oxygen species mediate angiotensin II-induced leukocyte-endothelial cell interactions in vivo. J Leukoc Biol. 2001;70:199-206.
20. Detmers PA, Zhou D, Polizzi E, et al. Role of stress-activated mitogen-activated protein kinase (p38) in beta 2-integrin-dependent neutrophil adhesion and the adhesion-dependent oxidative burst. J Immunol. 1998;161:1921-1929.
21. El Benna J, Han J, Park JW, Schmid E, Ulevitch RJ, Babior BM. Activation of p38 in stimulated human neutrophils: phosphorylation of the oxidase component p47phox by p38 and ERK but not by JNK. Arch Biochem Biophys. 1996;334:395-400.
22. Fialkow L, Chan CK, Rotin D, Grinstein S, Downey GP. Activation of the mitogen-activated protein kinase signaling pathway in neutrophils: role of oxidants. J Biol Chem. 1994;269:31234-31242.
23. McLeish KR, Klein JB, Coxon PY, Head KZ, Ward RA. Bacterial phagocytosis activates extracellular signal-regulated kinase and p38 mitogen-activated protein kinase cascades in human neutrophils. J Leukoc Biol. 1998;64:835-844.
24. Leto TL, Garrett MC, Fujii H, Nunoi H. Characterization of neutrophil NADPH oxidase factors p47-phox and p67-phox from recombinant baculoviruses. J Biol Chem. 1991;266:19812-19818.
25. Monteseiriνn J, Camacho MJ, Montaño R, et al. Enhancement of antigen-specific functional responses by neutrophils from allergic patients. J Exp Med. 1996;583:2571-2579.
26. Li Y, Zhu H, Kuppusamy P, Roubad U, Zweir JL, Trush MA. Validation of lucigenin (Bis-N-methylacridinium) as a chemilumigenic probe for detecting superoxide anion radical production by enzymatic and cellular systems. J Biol Chem. 1998;273:2015-2023.
27. McCord JM, Fridovich I. Superoxide dismutase: an enzymatic function for erythrocuprein. J Biol Chem. 1996;244:6049-6055.
28. Pick E, Keisari Y. A simple colometric method for the measurement of hydrogen peroxide produced by cells in culture. J Immunol Methods. 1980;38:161-170.
29. El Bekay R, Alvarez M, Carballo M, et al. Activation of phagocytic cell NADPH oxidase by norfloxacin: a potential mechanism to explain its bactericidal action. J Leukoc Biol. 2002;71:255-261.
30. Mansfield MA. Rapid immunodetection on polyvinylidene fluoride membrane blots without blocking. Anal Biochem. 1995;229:140-143.
31. Carballo M, Marquez G, Conde M, et al. Complete characterization of calcineurin in human neutrophils: inhibitory effect of hydrogen peroxide on its enzyme activity and on NF-κB DNA binding. J Biol Chem. 1999;274:93-100.
32. 2+ concentration in Fura-2-loaded human neutrophils. Biochem J. 1990;265:915-918.
33. Markham A, Spencer CM, Jarvis B. Irbesartan: an updated review of its use in cardiovascular disorders. Drugs. 2000;59:1187-1206.
34. Guthrie LA, McPhail LC, Henson PM, Johnston RB Jr. Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysacchadde: evidence for increased activity of the superoxide-producing enzyme. J Exp Med. 1984;160:1656-1671.
35. Fessler MB, Malcolm KC, Duncan MW, Worthen GS. A genomic and proteomic analysis of activation of the human neutrophil by lipopolysaccharide and its mediation by p38 mitogen-activated protein kinase. J Biol Chem. 2002;277:31291-31302.
36. Kowanko IC, Ferrante A. Stimulation of neutrophil respiratory burst and lysosomal enzyme release by human interferon-gamma. Immunology. 1987;62:149-151.
37. Gomez-Cambronero J, Colasanto JM, Huang CK, Sha'afi RI. Direct stimulation by tyrosine phosphorylation of microtubule-associated protein (MAP) kinase activity by granulocyte-macrophage colony-stimulating factor in human neutrophils. Biochem J. 1993;291:211-217.
38. Krump E, Sanghera JS, Pelech SL, Furuya W, Grinstein S. Chemotactic peptide N-formyl-Met-Leu-Phe activation of p38 mitogen-activated protein kinase (MAPK) and MAPK-activated protein kinase-2 in human neutrophils. J Biol Chem. 1997;272:937-944.
39. Nick JA, Avdi JN, Young S, et al. Selective activation and functional significance of p38 alpha mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophils. J Clin Invest. 1999;103:851-858.
40. Worthen GS, Avdi N, Buhl AM, Suzuki N, Johnson GL. fMLP activates Ras and Raf in human neutrophils: potential role in activation of MAP kinase. J Clin Invest. 1994;94:815-823.
41. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR. PD089059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem. 1995;270:27489-27494.
42. Cuenda A, Rouse J, Doza YN, et al. SB203580 is a specific inhibitor of MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 1995;364:229-233.
43. Avdi NJ, Malcolm KC, Nick JA, Worthen GS. A role for protein phosphatase-2A in p38 mitogen-activated protein kinase-mediated regulation of the c-Jun NH(2)-terminal kinase pathway in human neutrophils. J Biol Chem. 2002;277:40687-40696.
44. Cross AR. Inhibitors of the leukocyte superoxide generating oxidase: mechanisms of action and methods for their elucidation. Free Radical Biol Med. 1990;8:71-93.
45. Satriano J, Schlondorff D. Activation and attenuation of transcription factor NF-κB in mouse glomerular mesangial cells in response to tumor necrosis factor-alpha, immunoglobulin G, and adenosine 3′:5′-cyclic monophosphate: evidence for involvement of reactive oxygen species. J Clin Invest. 1994;94:1629-1636.
46. Diatchuck V, Lotan O, Koshkin V, Wikstroem P, Pick E. Inhibition of NADPH oxidase activation by 4-(2-aminoethyl)-benzenesulfonyl fluoride and related compounds. J Biol Chem. 1997;272:13292-13301.
47. Tian Y, Smith R, Balla T, Catt JK. Angiotensin II activates mitogen-activation protein kinase via protein kinase C and Ras/Raf-1 kinase in bovine adrenal glomerulosa cells. Endocrinology. 1998;139:1801-1807.
48. Adler V, Polotskaya A, Wagner F, Kraft AS. Affinity-purified c-Jun amino-terminal protein kinase requires serine/threonine phosphorylation for activity. J Biol Chem. 1992;267:17001-17005.
49. Avdi NJ, Nick JA, Whitlock BB, et al. Tumor necrosis factor-alpha activation of the c-Jun N-terminal kinase pathway in human neutrophils: integrin involvement in a pathway leading from cytoplasmic tyrosine kinases apoptosis. J Biol Chem. 2001;276:2189-2199.
50. 2+ signaling by angiotensin II in human vascular smooth muscle cells. J Hypertens. 2001;19:441-449.
51. Lim HW, New L, Han J, Molkentin JD. Calcineurin enhances MAPK phosphatase-1 expression and p38 MAPK inactivation in cardiac myocytes. J Biol Chem. 2001;276:15913-15919.
52. Lim HW, De Windt LJ, Steimberg L, et al. Calcineurin expression, activation, and function in cardiac pressure-overload hypertrophy. Circulation. 2000;101:2431-2437.
53. Sano M, Fukuda K, Sato T, et al. ERK and p38 MAPK, but not NF-κB, are critically involved in reactive oxygen species-mediated induction of IL-6 by angiotensin II in cardiac fibroblasts. Circ Res. 2001;89:661-669.
54. Kumar KV, Das UN. Are free radicals involved in the pathobiology of human essential hypertension? Free Radical Res Commun. 1993;19:59-66.
55. Kudoh S, Komuro I, Mizuno T, et al. Angiotensin II stimulates c-Jun NH2-terminal kinase in cultured cardiac myocytes of neonatal rats. Circ Res. 1997;80:139-146.
56. Yu H, Suchard JS, Nairn R, Jove R. Dissociation of mitogen-activated protein kinase activation from the oxidative burst in differentiated HL-60 cells and human neutrophils. J Biol Chem. 1995;270:15719-15724.
57. 2+ and PKC in activation of mitogen-activated protein (MAP) kinase in human polymorphonuclear neutrophils. J Physiol. 1998;513:359-367.
58. Frank GD, Eguchi S, Yamakawa T, Tanaka S, Inagami T, Motley ED. Involvement of reactive oxygen species in the activation of tyrosine kinase and extracellular signal-regulated kinase by angiotensin II. Endocrinology. 2000;141:3120-3126.
59. Zu YL, Qi J, Gilchrist A, et al. p36 mitogen-activated protein kinase activation is required for human neutrophil function triggered by TNF-alpha or fMLP stimulation. J Immunol. 1998;160:1982-1989.
60. Chang LC, Wang JP. Activation of p38 mitogen-activated protein kinase by formyl-methionylleucyl-phenylalanine in rat neutrophils. Eur J Pharmacol. 2000;390:61-66.
61. Takahashi T, Kawahara Y, Okuda M, Ueno H, Takeshita A, Yokoyama M. Angiotensin II stimulates mitogen-activated protein kinases and protein synthesis by a Ras-independent pathway in vascular smooth muscle cells. J Biol Chem. 1997;272:16018-16022.
62. Sue-A-Quan AK, Fialkow L, Vlahos CJ, et al. Inhibition of neutrophil oxidative burst and granule secretion by wortmannin: potential role of MAP kinase and renaturable kinases. J Cell Physiol. 1997;172:94-108.
63. Karlsson A, Nixon JB, McPhail LC. Phorbol myristate acetate induces neutrophil NADPH-oxidase activity by two separate signal transduction pathways: dependent or independent of phosphatidylinositol 3-kinase. J Leukoc Biol. 2000;67:396-404.
64. Ferby IM, Waga I, Sakanaka C, Kume K, Shimizu T. Wortmannin inhibits mitogen-activated protein kinase activation induced by platelet-activating factor in guinea pig neutrophils. J Biol Chem. 1994;269:30485-30488.
65. Eguchi S, Dempsey PJ, Frank GD, Motley ED, Inagami T. Activation of MAPKs by angiotensin II in vascular smooth muscle cells: metalloprotease-dependent EGF receptor activation is required for activation of ERK and p36MAPK but not for JNK. J Biol Chem. 2001;276:7957-7962.
66. 2-terminal kinase. J Biol Chem. 2000;275:26856-26863.
67. Nataraj C, Oliverio MI, Mannon R-B. Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway. J Clin Invest. 1999;104:1693-1701.
68. Werlen G, Jacinto E, Xia Y, Karin M. Calcineurin preferentially synergizes with PKC-theta to activate JNK and IL-2 promoter in T lymphocytes. EMBO J. 1998;17:3101-3111.
69. Murat A, Pellieux C, Brunner HR, Pedrazzini T. Calcineurin blockade prevents cardiac mitogen-activated protein kinase activation and hypertrophy in renovascular hypertension. J Biol Chem. 2000;275:40867-40873.
70. Bokoch GM, Knaus UG. Ras-related GTP-binding proteins and leukocyte signal transduction. Curr Opin Hematol. 1994;1:53-60.
71. Kwong CH, Malech HL, Rotrosen D, Leto TL. Regulation of the human neutrophil NADPH oxidase by rho-related G-proteins. Biochemistry. 1993;32:5711-5717.
72. Baukal AJ, Hunyady L, Catt KJ, Balla T. Evidence for participation of calcineurin in potentiation of agonist-stimulated cyclic AMP formation by the calcium-mobilizing hormone, angiotensin II. J Biol Chem. 1994;269:24546-24549.
73. Kranzhofer R, Browatzki M, Schmidt J, Kubler W. Angiotensin II activates the proinflammatory transcription factor nuclear factor-κB in human monocytes. Biochem Biophys Res Commun. 1999;257:826-828.
74. Kalra D, Sivasubramanian N, Mann DL. Angiotensin II induces tumor necrosis factor biosynthesis in the adult mammalian heart through a protein kinase C-dependent pathway. Circulation. 2002;105:2198-2205.
75. Dzau VJ. Vascular wall renin-angiotensin pathway in control of the circulation: a hypothesis. Am J Med. 1984;77:31-36.
76. Guba M, Steinbauer M, Buchner M, et al. Differential effects of short-term ace- and AT1-receptor inhibition on postischemic injury and leukocyte adherence in vivo and in vitro. Shock. 2000;13:190-196.
77. Postnov YV. An approach to the explanation of cell membrane alteration in primary hypertension. Hypertension. 1990;15:332-337.